Shalaleh Aghaei; Roghaye Mohammadirad; Azita Fathnezhad-Kazemi
Abstract
Introduction: There is scarce information about the effects of SARS‐CoV‐2 infection in pregnant women. The present study aimed to evaluate pregnancy’s clinical characteristics and outcomes in women with COVID-19 and their babies.Case Presentation: We conducted a case series study, from April ...
Read More
Introduction: There is scarce information about the effects of SARS‐CoV‐2 infection in pregnant women. The present study aimed to evaluate pregnancy’s clinical characteristics and outcomes in women with COVID-19 and their babies.Case Presentation: We conducted a case series study, from April 15 to May 30, 2021, including 24 cases with COVID-19 infection and their babies with a 30-day follow-up after delivery. The patients’ mean (SD) age of was 31.50 (5.69) years, and all the deliveries were in the third trimester. Fever and myalgia were the most prevalent clinical symptoms in women. Positive RTPCR test results [in 20 pateints (83.33%)], and CT scan findings [in four patients (16.67%)] confirmed the diagnosis. Moreover, 66.66% of pregnant women with COVID-19 underwent Cesarean section. Performing a Cesarean section was mostly due to obstetric indications or the mother’s request. None of the babies were positive PCR. Out of eight preterm infants, seven were admitted to the intensive care unit (NICU) for reasons other than COVID-19.Conclusion: The most common obstetric outcomes were high rates of premature delivery and Cesarean section. Additionally, the most prevalent neonatal consequences were prematurity and low birth weight. There was; however, no evidence of intrauterine vertical transmission.
